ArticleAlzheimer's research & therapy2017

Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.

Jong-Chan Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.